Journal of Research in Ayurvedic Sciences

Register      Login

VOLUME 1 , ISSUE 4 ( October-December, 2017 ) > List of Articles

RESEARCH ARTICLE

Clinical Safety of Selected Ayurvedic Formulations in Common Eye Diseases

Alok Srivastava, Vanmala B Wakode

Keywords : Anu taila, Computer vision syndrome, Dry eye syndrome, Mahatriphaladya ghrita, Triphala kwath,Allergic conjunctivitis

Citation Information : Srivastava A, Wakode VB. Clinical Safety of Selected Ayurvedic Formulations in Common Eye Diseases. J Res Ayurvedic Sci 2017; 1 (4):223-230.

DOI: 10.5005/jp-journals-10064-0022

License: CC BY-NC 3.0

Published Online: 00-12-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Allergic conjunctivitis (AC), dry eye syndrome (DES), and computer vision syndrome (CVS) are few of the eye diseases that commonly affect the working class. Allergic conjunctivitis is often associated with Kaphaja abhishyanda. Dry eye syndrome is caused due to chronic lack of sufficient lubrication and moisture on the surface of the eye. The CVS is a visual complaint that is clinically similar to DES. In Ayurveda, the symptoms of DES can be included under the spectrum of two different diseases, Krichronmeela and suskakshipaka. Tarpana, Aschyotana, Nasya, and oral use of Ayurvedic medicines are commonly advocated for eye diseases. Objective: Critical analysis and presentation of clinical safety and efficacy outcomes of classical Ayurvedic formulations, viz., Mahatriphaladya ghrita, Triphala kwatha, and Anu taila, in patients of common eye diseases. Materials and methods: Data were collected from three different clinical studies, viz., AC, DES, and CVS, that have been completed in peripheral institutes of Central Council for Research in Ayurvedic Sciences (CCRAS) and were critically evaluated to assay the safety profile of three drugs. Clinical safety assessments were done through analyzing liver function tests (LFTs) and kidney function tests (KFTs) before and after the trial period. Paired sample t-test was used to compare the mean changes from baseline to the end of the trial period. The study revealed that all the parameters were within the specified limits during the entire period. Conclusion: The findings in the three different clinical studies clearly reveal that Mahatriphaladya ghrita, Triphala kwath, and Anu taila are clinically safe, effective, and tolerable in common eye diseases.


PDF Share
  1. La Rosa M, Lionetti E, Reibaldi M, Russo A, Longo A, Leonardi S, Tomarchio S, Avitabile T, Reibaldi A. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 2013 Mar;39:18.
  2. Phadatare SP, Momin M, Nighojkar P, Askarkar S, Singh KK. A comprehensive review on dry eye disease: diagnosis, medical management, recent development, and future challenges. Adv Pharm 2015 Jan;2015:704946.
  3. Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K. Abnormal protein profiles in tear with dry eye syndrome. Am J Ophthalmol 2003 Aug;136(2):291-299.
  4. Wimalasundera S. Computer vision syndrome. Galle Med J 2009 Sep;11(1):25-29.
  5. Blehm C, Vishnu S, Khattak A, Mitra S, Yee RW. Computer vision syndrome: a review. Surv Ophthalmol 2005 May- Jun;50(3):253-262.
  6. Hazarika AK, Singh PK. Computer vision syndrome. SMU Med J 2014 Jul;1(2):132-138.
  7. Vaidya, BHP. Ashtanga Hridaya by Vagbhata, with commentaries of Arunadatta and Hemadri chapter 15/16 utharasthana. 8th ed. Varanasi: chaukhambha orientalia.
  8. Sushrut Samhita, uttartantram, sarvagatrog vidyaniya 6/16. p. 1100.
  9. Leonardi S, Marchese G, Marseglia GL, La Rosa M. Montelukast in allergic diseases beyond asthma. Allergy Asthma Proc 2007 May-Jun;28(3):287-291.
  10. Anonymous. The Ayurvedic Pharmacopoeia of India (Ministry of Health and Family Welfare, Govt. of India, New Delhi): part II. 1st ed. Vol. 2. New Delhi: The Controller of Publications; 2010.
  11. Anonymous. The Ayurvedic Formulary of India (AFI) (Ministry of Health and Family Welfare, Govt. of India, New Delhi): part II. 1st ed. New Delhi: The Controller of Publications; 2000. p. 71.
  12. Anonymous. The Ayurvedic Pharmacopoeia of India (Ministry of Health and Family Welfare, Govt. of India, New Delhi): part II. 1st ed. Vol. 3. New Delhi: The Controller of Publications; 2010.
PDF Share